Germany Flow Cytometry Market Size & Outlook, 2023-2030
Germany flow cytometry market, 2018-2030 (US$M)
Related Markets
Germany flow cytometry market highlights
- The Germany flow cytometry market generated a revenue of USD 332.1 million in 2023 and is expected to reach USD 555.6 million by 2030.
- The Germany market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 332.1 million |
| Market revenue in 2030 | USD 555.6 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, Germany accounted for 7.7% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 403.0 million by 2030.
Instruments was the largest segment with a revenue share of 35.8% in 2023. Horizon Databook has segmented the Germany flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Germany flow cytometry market was valued at USD 347.1 million in 2021 and is expected to grow at a CAGR of 6.76% during the forecast period, to reach an expected value of USD 685.2 million in 2030. Germany accounted for the largest revenue share of Europe flow cytometry market, owing to its established biopharmaceutical industry, increasing R&D activities by biopharmaceutical companies, and high prevalence of chronic diseases, such as cancer & diabetes.
For instance, according to GLOBOCAN, in 2020, around 6,28,519 new cases of cancer were diagnosed in Germany. Furthermore, a high number of COVID-19 cases and extensive R&D activities by regional players to develop novel vaccines for the disease are anticipated to create significant demand for flow cytometry solutions for research and clinical applications.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany flow cytometry market size, by product, 2018-2030 (US$M)
Germany Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
